Cannabinoid receptors and immunity

Immunology Today

Volumn 19, Issue 8, 1998, Pages 373-381

  Klein, Thomas W ^a   Newton, Cathy ^a   Friedman, Herman ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; CYTOKINE;

B LYMPHOCYTE; HUMAN; IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; MACROPHAGE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; T LYMPHOCYTE;

EID: 0031811925     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(98)01300-0     Document Type: Review

References (75)

1. Razdan R.K. Pharmacol. Rev. 38:1986;75-149.
2. Howlett A.C. Annu. Rev. Pharmacol. Toxicol. 35:1995;607-634.
3. Abood M.E., Martin B.R. Int. Rev. Neurobiol. 39:1996;197-221.
4. Gaoni Y., Mechoulam R. J. Am. Chem. Soc. 86:1964;1646-1647.
5. Howlett A.C., Johnson M.R., Melvin L.S., Milne G.M. Mol. Pharmacol. 33:1988;297-302.
6. Mechoulam R., Feigenbaum J.J., Lander N.et al. Experientia. 44:1988;762-764.
7. Bell M.R., D'Ambra T.E., Kumar V.et al. J. Med. Chem. 34:1991;1099-1110.
8. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Nature. 346:1990;561-564.
9. Gerard C.M., Mollereau C., Vassart G., Parmentier M. Biochem. J. 279:1991;129-134.
10. Chakrabarti A., Onaivi E., Chaudhuri G. DNA Seq. 5:1995;385-388.
11. Yamaguchi F., Macrae A.D., Brenner S. Genomics. 35:1996;603-605.
12. Munro S., Thomas K.L., Abu-Shaar M. Nature. 365:1993;61-65.
13. Rinaldi-Carmona M., Calandra B., Shire D.et al. J. Pharm. Exp. Ther. 278:1996;871-878.
14. Bonner T.I. J. Neuroimmunol. 69:1996;15-17.
15. Devane W.A., Hanus L., Breuer A.et al. Science. 258:1992;1946-1949.
16. Thomas B.F., Adams I.B., Mascarella S.W., Martin B.R., Razdan R.K. J. Med. Chem. 39:1996;471-479.
17. Mechoulam R., Hanus L., Martin B.R. Biochem. Pharmacol. 48:1994;1537-1544.
18. Klein T., Friedman H., Specter S. J. Neuroimmunol. 83:1998;102-115.
19. Nahas G.G., Suciu-Foca N., Armand J-P., Morishima A. Science. 183:1974;419-420.
20. Petersen B.H., Graham J., Lemberger L. Life Sci. 19:1976;395-400.
21. Lau R.J., Tubergen D.G., Barr M., Domino E.F. Science. 192:1976;805-807.
22. White S.C., Brin S.C., Janicki B.W. Science. 188:1975;71-72.
23. Gupta S., Grieco M.H., Cushman P. New Engl. J. Med. 291:1974;874-876.
24. Wallace J.M., Tashkin D.P., Oishi J.S., Barbers R.G. J. Psychoact. Drugs. 20:1988;9-14.
25. Nahas G.G., Morishima A., Desoize B. Fed. Proc. 36:1977;1748-1752.
26. Klein T.W., Newton C.A., Widen R., Friedman H. J. Immunopharmacol. 7:1985;451-466.
27. Pross S.H., Nakano Y., Widen R.et al. Int. J. Immunopharmacol. 14:1992;1019-1027.
28. Luo Y.D., Patel M.K., Wiederhold M.D., Ou D.W. Int. J. Immunopharmacol. 14:1992;49-56.
29. Lee M., Yang K.H., Kaminski N.E. J. Pharm. Exp. Ther. 275:1995;529-536.
30. Klein T.W., Kawakami Y., Newton C., Friedman H. J. Toxicol. Environ. Health. 32:1991;465-477.
31. Nahas, G.G. and Osserman, E.F. (1991) in Advances in Experimental Medicine and Biology 288: Drugs of Abuse, Immunity and Immunodeficiency (Friedman, H., Specter, S. and Klein, T.W., eds), pp. 25-32, Plenum Press.
32. Rachelefsky G.S., Opelz G., Mickey M.R.et al. J. Allergy Clin. Immunol. 58:1976;483-490.
33. Zimmerman S., Zimmerman A.M., Cameron I.L., Laurence H.L. Pharmacology. 15:1977;10-23.
34. Smith S.H., Harris L.S., Uwaydah I.M., Munson A.E. J. Pharmacol. Exp. Ther. 207:1978;165-170.
35. Baczynsky W.O.T., Zimmerman A.M. Pharmacology. 26:1983;12-19.
36. Klein, T.W. and Friedman, H. (1990) in Drugs of Abuse and Immune Function (Watson, R., ed.), pp. 87-111, CRC Press.
37. Kaminski N.E., Abood M.E., Kessler F.K., Martin B.R., Schatz A.R. Mol. Pharmacol. 42:1992;736-742.
38. Schatz A.R., Koh W.S., Kaminski N.E. Immunopharmacology. 26:1993;129-137.
39. Derocq J., Segui M., Marchand J., LeFur G., Casellas P. FEBS Lett. 369:1995;177-182.
40. Mann P.G., Cohen A.B., Finley T.N., Ladman A.J. Lab. Invest. 25:1971;111-120.
41. Drath D.B., Shorey J.M., Price L., Huber G.L. Infect. Immun. 25:1979;268-272.
42. Lopez-Cepero M., Friedman M., Klein T., Friedman H. J. Leukocyte Biol. 39:1986;679-686.
43. Cabral G.A., Mishkin E.M. J. Toxicol. Environ. Health. 26:1989;175-182.
44. Burnette-Curley D., Marciano-Cabral F., Fischer-Stenger K., Cabral G.A. Int. J. Immunopharmacol. 15:1993;371-382.
45. McCoy K.L., Gainey D., Cabral G.A. J. Pharmacol. Exp. Ther. 273:1995;1216-1223.
46. Burstein S., Budrow J., Debatis M., Hunter S.A., Subramanian A. Biochem. Pharmacol. 48:1994;1253-1264.
47. Jeon Y.J., Yang K., Pulaski J.T., Kaminski N.E. Mol. Pharmacol. 50:1996;334-341.
48. Stefano G.B., Liu Y., Goligorsky M.S. J. Biol. Chem. 271:1996;19238-19242.
49. Dax E.M., Pilotte N.S., Adler W.H., Nagel J.E., Lange W.R. J. Steroid Biochem. 34:1989;263-270.
50. Specter S., Klein T.W., Newton C.et al. Int. J. Immunopharmacol. 8:1986;741-745.
51. Patel V., Borysenko M., Kumar M.S.A., Millard W.J. Proc. Soc. Exp. Biol. Med. 180:1985;400-404.
52. Klein T.W., Newton C., Friedman H. J. Toxicol. Environ. Health. 20:1987;321-332.
53. Kawakami Y., Klein T.W., Newton C.et al. Int. J. Immunopharmacol. 10:1988;485-488.
54. Blanchard D.K., Newton C., Klein T.W., Stewart W.E. III, Friedman H. Int. J. Immunopharmacol. 8:1986;819-824.
55. Cabral G.A., Lockmuller J.C., Mishkin E.M. Proc. Soc. Exp. Biol. Med. 181:1986;305-311.
56. Nakano Y., Pross S.H., Friedman H. Proc. Soc. Exp. Biol. Med. 201:1992;165-168.
57. Zhu W., Igarashi T., Friedman H., Klein T.W. J. Pharmacol. Exp. Ther. 274:1995;1001-1007.
58. Zhu W., Newton C., Daaka Y., Friedman H., Klein T.W. J. Pharmacol. Exp. Ther. 270:1994;1334-1339.
59. Klein T.W., Newton C., Widen R., Friedman H. J. Pharmacol. Exp. Ther. 267:1993;635-640.
60. Zheng Z-M., Specter S., Friedman H. Int. J. Immunopharmacol. 14:1992;1445-1452.
61. Fischer-Stenger K., Dove Pettit D.A., Cabral G.A. J. Pharmacol. Exp. Ther. 267:1993;1558-1565.
62. Mosmann T.R., Sad S. Immunol. Today. 17:1996;138-146.
63. Klein T.W., Newton C., Friedman H. J. Infect. Dis. 169:1994;1177-1179.
64. Newton C.A., Klein T.W., Friedman H. Infect. Immun. 62:1994;4015-4020.
65. Clerici M., Shearer G.M. Immunol. Today. 14:1993;107-111.
66. Bouaboula M., Rinaldi M., Carayon P.et al. Eur. J. Biochem. 214:1993;173-180.
67. Klein T.W., Newton C., Zhu W., Daaka Y., Friedman H. Proc. Soc. Exp. Biol. Med. 209:1995;205-212.
68. Schatz A.R., Lee M., Condie R.B., Pulaski J.T., Kaminski N.E. Toxicol. Appl. Pharmacol. 142:1997;278-287.
69. Galieque S., Mary S., Marchand J.et al. Eur. J. Biochem. 232:1995;54-61.
70. Daaka Y., Friedman H., Klein T.W. J. Pharmacol. Exp. Ther. 276:1996;776-783.
71. Brown K.D., Zurawski S.M., Mosmann T.R., Zurawski G. J. Immunol. 142:1989;679-687.
72. Hunter S.A., Burstein S.H. Life Sci. 60:1997;1563-1573.
73. Shire D., Calandra B., Delpech M.et al. J. Biol. Chem. 271:1996;6941-6946.
74. Song Z-H., Bonner T.I. Mol. Pharmacol. 49:1996;891-896.
75. Szalay G., Ladel C.H., Blum C., Kaufmann S.H.E. J. Immunol. 157:1996;4746-4750.